# Conair Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/conair-medical

- Industry: Medical Devices & Equipment
- Headquarters: Tel Aviv, Israel
- Website: www.conairmedical.com/
- Latest round: Seed (Nov 1, 2023)
- Investors on record: 1

## About

Based in Tel Aviv, Israel, Conair Medical is a healthcare company focused on developing advanced medical devices that enhance patient care and optimize clinical workflows for respiratory therapy.Conair Medical specializes in medical devices, particularly in respiratory therapy. Founded in Tel Aviv, Israel, the company has effectively positioned itself within the healthcare sector. In November 2023, Conair Medical raised seed funding from Peregrine Ventures, marking a significant step in its growth strategy. The company has completed a total of 1 deal as of the most recent deal date.Conair Medical specializes in innovative healthcare solutions, focusing primarily on advanced medical devices designed to enhance patient care and streamline clinical workflows. Their core product offerings include a range of respiratory therapy devices, such as nebulizers and airway management systems, aimed at treating patients with chronic respiratory conditions. The company’s products are engineered for effective treatment while ensuring ease of use for healthcare professionals and patients. Their end-users encompass hospitals, outpatient clinics, and home healthcare providers across the United States, Europe, and select markets in Asia. By addressing critical needs in respiratory management and patient monitoring, Conair Medical plays a pivotal role in improving health outcomes for individuals requiring respiratory support.Conair Medical generates revenue through direct sales of its medical devices to healthcare facilities and home care providers, operating within a B2B transaction structure. The company’s flagship products contribute significantly to its revenue, with transactions typically occurring through direct procurement by hospitals and clinics. Pricing structures for these medical devices reflect the quality and technological advancements of the products, with specific offerings tailored to various healthcare settings. Additionally, the company may engage in partnerships with healthcare distributors, expanding its market reach and ensuring availability across multiple regions. This dynamic transaction model supports continuous revenue generation, bolstered by a commitment to innovation in respiratory care.Conair Medical is actively pursuing the development of new products designed to enhance respiratory therapy solutions, with specific launch dates to be confirmed. The company plans to expand into additional markets in Europe and Asia, aiming for a broader reach by 2024. The recent seed funding raised in November 2023 will be utilized to support these product development initiatives and facilitate market expansion efforts.

## Funding rounds

- Seed, Nov 1, 2023 — Peregrine Ventures

## Investors

- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Seed